Sight Sciences Capex To Revenue Over Time
| SGHT Stock | USD 3.98 0.03 0.75% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sight Sciences Performance and Sight Sciences Correlation. Sight |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sight Sciences. If investors know Sight will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sight Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.01) | Revenue Per Share 1.602 | Quarterly Revenue Growth 0.007 | Return On Assets (0.19) | Return On Equity (0.45) |
The market value of Sight Sciences is measured differently than its book value, which is the value of Sight that is recorded on the company's balance sheet. Investors also form their own opinion of Sight Sciences' value that differs from its market value or its book value, called intrinsic value, which is Sight Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sight Sciences' market value can be influenced by many factors that don't directly affect Sight Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sight Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sight Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sight Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Capex To Revenue Analysis
Compare Sight Sciences and related stocks such as Si Bone, Rapid Micro Biosystems, and Tactile Systems Tech Capex To Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SIBN | 0.0011 | 0.0011 | 0.0011 | 0.015 | 0.0716 | 0.0544 | 0.0105 | 0.01 | 0.017 | 0.0363 | 0.0349 | 0.0709 | 0.0893 | 0.0562 | 0.0311 |
| RPID | 0.1027 | 0.1027 | 0.1027 | 0.1027 | 0.1027 | 0.1027 | 0.1027 | 0.1027 | 0.1027 | 0.1027 | 0.0429 | 0.1385 | 0.3934 | 0.0819 | 0.12 |
| TCMD | 0.0098 | 0.0098 | 0.0098 | 0.0098 | 0.0074 | 0.0098 | 0.0099 | 0.035 | 0.0664 | 0.0316 | 0.0122 | 0.0113 | 0.0078 | 0.0085 | 0.0153 |
| LUNG | 0.0158 | 0.0158 | 0.0158 | 0.0158 | 0.0158 | 0.0158 | 0.0158 | 0.0158 | 0.0158 | 0.0221 | 0.0278 | 0.0758 | 0.0246 | 0.0118 | 0.0112 |
| AORT | 0.0392 | 0.0212 | 0.0233 | 0.0308 | 0.0368 | 0.0281 | 0.0412 | 0.0371 | 0.022 | 0.0292 | 0.0289 | 0.0438 | 0.0341 | 0.021 | 0.0199 |
| ANIK | 0.6364 | 0.0216 | 0.0211 | 0.0059 | 0.0147 | 0.0992 | 0.1356 | 0.0792 | 0.0441 | 0.0247 | 0.0125 | 0.0348 | 0.0479 | 0.0326 | 0.0309 |
| OFIX | 0.0214 | 0.0445 | 0.0622 | 0.0755 | 0.0461 | 0.0704 | 0.0447 | 0.0391 | 0.0337 | 0.0446 | 0.042 | 0.0422 | 0.0503 | 0.0831 | 0.0873 |
| AVNS | 0.0239 | 0.0239 | 0.0242 | 0.0292 | 0.0469 | 0.0447 | 0.0183 | 0.0706 | 0.0753 | 0.0725 | 0.0283 | 0.0282 | 0.0235 | 0.0264 | 0.0315 |
| FNA | 0.1697 | 0.1697 | 0.1697 | 0.1697 | 0.1697 | 0.1697 | 0.1697 | 0.1697 | 0.1697 | 0.1697 | 0.0977 | 0.1444 | 0.2375 | 0.1295 | 0.13 |
| VREX | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0185 | 0.0332 | 0.0332 | 0.0332 | 0.0248 |
| KIDS | 0.1401 | 0.1401 | 0.1401 | 0.1401 | 0.1401 | 0.0726 | 0.1275 | 0.1434 | 0.0949 | 0.1666 | 0.159 | 0.1633 | 0.082 | 0.1276 | 0.1 |
| NPCE | 0.0127 | 0.0127 | 0.0127 | 0.0127 | 0.0127 | 0.0127 | 0.0127 | 0.0127 | 0.0127 | 0.0127 | 0.0015 | 0.0085 | 0.0132 | 0.0026 | 0.0025 |
| CVRX | 0.0169 | 0.0169 | 0.0169 | 0.0169 | 0.0169 | 0.0169 | 0.0169 | 0.0169 | 0.0169 | 0.0169 | 0.0514 | 0.0907 | 0.0305 | 0.015 | 0.0143 |
| CNMD | 0.0309 | 0.03 | 0.0281 | 0.0244 | 0.021 | 0.0209 | 0.0193 | 0.0161 | 0.0192 | 0.021 | 0.0151 | 0.0147 | 0.0208 | 0.0153 | 0.0146 |
Sight Sciences and related stocks such as Si Bone, Rapid Micro Biosystems, and Tactile Systems Tech Capex To Revenue description
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.My Equities
My Current Equities and Potential Positions
| Sight Sciences | SGHT |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.98
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.